口蹄疫ワクチンの世界市場レポート 2024年

口蹄疫ワクチンの市場規模は近年力強く成長しています。2023年の24億米ドルから2024年には26億3,000万米ドルへと、CAGR9.6％で拡大します。過去数年間の成長は、多価ワクチン開発の進歩、口蹄疫の流行、疾病管理に対する政府の取り組み、食糧安全保障の重視、口蹄疫発生による経済的影響、研究開発への多額の投資に起因しています。

アジア太平洋は2023年の口蹄疫ワクチン市場において最大の地域です。口蹄疫ワクチン市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の口蹄疫ワクチン市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の口蹄疫ワクチン市場規模実績と成長、2018～2023年
• 世界の口蹄疫ワクチン市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の口蹄疫ワクチン市場、ワクチンのタイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 従来のワクチン
• 石油ベースのワクチン
• 水酸化アルミニウム/サポニンベースのワクチン
• 緊急ワクチン
• 世界の口蹄疫ワクチン市場、動物のタイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 牛
• 豚
• 羊とヤギ
• その他
• 世界の口蹄疫ワクチン市場、流通チャネル別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 政府機関
• 販売店・薬局
• 民間獣医師
• その他

第7章 地域と国の分析

• 世界の口蹄疫ワクチン市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の口蹄疫ワクチン市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 口蹄疫ワクチン市場の競合情勢
• 口蹄疫ワクチン市場企業プロファイル
  • Godrej Agrovet Limited
  • Biogenesis Bago SA
  • Indian Immunologicals Limited
  • Limor de Colombia
  • Merck &Co. Inc

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

Foot And Mouth Disease Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on foot and mouth disease vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for foot and mouth disease vaccine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The foot and mouth disease vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Vaccine Type: Conventional Vaccines; Oil Based Vaccines; Aluminum Hydroxide/Saponin Based Vaccines; Emergency Vaccines
• 2) By Animal Type: Cattle; Pig; Sheep and Goat; Other Animals
• 3) By Distribution Channel: Government Organizations; Distributors/ Pharmacies; Private Vet; Other Distribution Channels
• Companies Mentioned: Godrej Agrovet Limited; Biogenesis Bago S.A.; Indian Immunologicals Limited; Limor de Colombia; Merck & Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Foot-and-mouth disease (FMD) vaccines serve as a crucial intervention to enhance the immune defenses of animals against the highly contagious foot-and-mouth disease. This disease poses a severe threat to all cloven-hoofed animals, including cattle, sheep, goats, camelids, deer, and pigs. Clinical signs of FMD in animals include elevated body temperature and the development of blisters, primarily affecting the feet and mouth.

The main categories of foot-and-mouth disease vaccines include conventional vaccines, oil-based vaccines, aluminum hydroxide/saponin-based vaccines, and emergency vaccines tailored for cattle, pigs, sheep, goats, and other susceptible animals. Conventional vaccines typically consist of inactivated disease-causing organisms or pathogen-derived proteins (antigens). These antigens mimic the infectious agent, working to stimulate the immune system. The goal is to prime the immune system, enabling it to respond more rapidly and effectively if the animal is exposed to the actual infectious agent. Distribution channels for foot-and-mouth disease vaccines are diverse and include government organizations, distributors/pharmacies, private veterinary services, and other relevant distribution channels. This widespread availability ensures that these vaccines can be efficiently disseminated to protect susceptible animal populations and prevent the spread of foot-and-mouth disease.

The foot and mouth disease vaccine market research report is one of a series of new reports from The Business Research Company that provides foot and mouth disease vaccine market statistics, including foot and mouth disease vaccine industry global market size, regional shares, competitors with a foot and mouth disease vaccine market share, detailed foot and mouth disease vaccine market segments, foot and mouth disease vaccine market trends and opportunities, and any further data you may need to thrive in the foot and mouth disease vaccine industry. This foot and mouth disease vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The foot and mouth disease vaccine market size has grown strongly in recent years. It will grow from $2.4 billion in 2023 to $2.63 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historical period can be ascribed to advancements in the development of multivalent vaccines, the prevalence of foot and mouth disease, governmental initiatives for disease control, a concentrated emphasis on food security, the economic ramifications of foot and mouth disease outbreaks, and substantial investments in research and development.

The foot and mouth disease vaccine market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The projected growth in the forecast period is associated with the impact of climate change on the spread of diseases, the emergence of new foot-and-mouth disease (FMD) strains, the adoption of a One Health approach, the digitalization of vaccine distribution, improvements in vaccine cold chain infrastructure, ongoing enhancements in vaccine safety, integration with precision livestock farming, and international support for vaccination programs. Key trends expected in the forecast period encompass global initiatives for FMD eradication, the development of multivalent vaccines, the formation of public-private partnerships, advancements in diagnostics and surveillance technologies, biotechnological innovations, genomic surveillance, and the increasing adoption of marker vaccines.

The foot and mouth disease vaccine market is experiencing growth driven by the expanding livestock population. Livestock, encompassing animals like cows, horses, and pigs, is on the rise due to increased demand for animal products. This growth in livestock presents a higher risk of foot and mouth disease prevalence, consequently boosting the demand for foot and mouth disease vaccines. Notably, in 2022, India's national cattle herd surged from 1.2 million in 2021 to 306.7 million, as reported by the US Department of Agriculture, exemplifying the significant impact of the growing livestock population on the foot and mouth disease vaccine market.

The upward trajectory in healthcare expenditure is expected to contribute to the foot and mouth disease vaccine market's growth. Healthcare expenditure, reflecting the total spending on healthcare goods and services, supports research and development activities in veterinary medicine. Increased funding in this sector facilitates the development of more advanced and effective vaccines, including those designed to prevent foot and mouth disease in animals. For example, the United Kingdom's healthcare spending reached approximately $352.69 billion in 2022, marking a modest increase of 0.7% from the previous year, as reported by the Office for National Statistics. This uptick in healthcare expenditure is a driving force behind the foot and mouth disease vaccine market's expansion.

A key trend in the foot and mouth disease vaccine market is the strategic partnership among major players. These collaborations allow companies to leverage each other's resources and expand into new markets. In July 2022, Biogenesis Bago, an Argentina-based biotech company specializing in foot-and-mouth disease vaccines, partnered with FVC to establish an advanced FMD vaccine facility in South Korea. This strategic partnership aims to provide South Korea with cutting-edge technologies for the production of high-quality FMD vaccines, enhance local livestock protection, and contribute to the country's sanitary status. FVC, a South Korea-based information technology services provider, complements the collaboration.

Major companies in the foot and mouth disease vaccine market are focusing on innovative services, including advancements in clinical phases, to enhance profitability. Clinical trials, which test new treatments and medications, play a crucial role in the development of effective vaccines. In June 2023, the Department of Animal Husbandry and Dairying in India launched the third phase of FMD Vaccination under the National Animal Disease Control Programme (NADCP). This initiative aims to combat foot and mouth disease in cattle, contributing to a broader strategy to manage and eventually eradicate FMD by 2030. The success of such initiatives is essential for improving local output, expanding exports of milk and animal products, and ensuring the profitability of major players in the foot and mouth disease vaccine market.

In May 2022, Ceva Sante Animale (Ceva), a prominent animal health company based in France, successfully acquired Artemis Technologies, Inc. for an undisclosed sum. This strategic acquisition aligns with Ceva's commitment to protecting humans, wildlife, pets, and livestock from the detrimental effects of lethal zoonotic diseases. Moreover, it reinforces Ceva's efforts in disease management within natural habitats. Artemis Technologies, Inc., headquartered in Canada, specializes in the production of oral rabies vaccines.

Major companies operating in the foot and mouth disease vaccine market report are Godrej Agrovet Limited, Biogenesis Bago S.A., Indian Immunologicals Limited, Limor de Colombia, Merck & Co. Inc., Brilliant Bio Pharma Ltd., Intervet India Private Limited, Biovet Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, VECOL S.A, VETAL Animal Health Products Inc., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Careside Co. Ltd., Dong Bang Co. Ltd., FGBI-ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, vetvaco national veterinary joint stock company, Ceva Sante Animale, MEVAC, Agrovet Market S.A., Alivira Animal Health Limited, Anicon Labor GmbH, Southern Cross Group, SPIC Gene Science Technology Development Co. Ltd., SRI International, Syngenta Animal Health, Vemedim Corporation, Veterinary Laboratories Agency, and Zoetis Inc.

Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2023. The regions covered in the foot and mouth disease vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the foot and mouth disease vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The foot and mouth disease vaccine market consist of sales of inactivated vaccine, viral vector vaccine, adenovirus, virus-like particle vaccines, baculovirus, plant-produced empty capsids, RNA vaccine, and DNA vaccine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Foot And Mouth Disease Vaccine Market Characteristics

3. Foot And Mouth Disease Vaccine Market Trends And Strategies

4. Foot And Mouth Disease Vaccine Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Foot And Mouth Disease Vaccine Market Size and Growth

• 5.1. Global Foot And Mouth Disease Vaccine Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Foot And Mouth Disease Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Foot And Mouth Disease Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Foot And Mouth Disease Vaccine Market Segmentation

• 6.1. Global Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Conventional Vaccines
• Oil Based Vaccines
• Aluminium Hydroxide/Saponin Based Vaccines
• Emergency Vaccines
• 6.2. Global Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cattle
• Pig
• Sheep and Goat
• Other Animals
• 6.3. Global Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Government Organizations
• Distributors/ Pharmacies
• Private Vet
• Other Distribution Channels

7. Foot And Mouth Disease Vaccine Market Regional And Country Analysis

• 7.1. Global Foot And Mouth Disease Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Foot And Mouth Disease Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Foot And Mouth Disease Vaccine Market

• 8.1. Asia-Pacific Foot And Mouth Disease Vaccine Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Foot And Mouth Disease Vaccine Market

• 9.1. China Foot And Mouth Disease Vaccine Market Overview
• 9.2. China Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Foot And Mouth Disease Vaccine Market

• 10.1. India Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Foot And Mouth Disease Vaccine Market

• 11.1. Japan Foot And Mouth Disease Vaccine Market Overview
• 11.2. Japan Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Foot And Mouth Disease Vaccine Market

• 12.1. Australia Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Foot And Mouth Disease Vaccine Market

• 13.1. Indonesia Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Foot And Mouth Disease Vaccine Market

• 14.1. South Korea Foot And Mouth Disease Vaccine Market Overview
• 14.2. South Korea Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Foot And Mouth Disease Vaccine Market

• 15.1. Western Europe Foot And Mouth Disease Vaccine Market Overview
• 15.2. Western Europe Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Foot And Mouth Disease Vaccine Market

• 16.1. UK Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Foot And Mouth Disease Vaccine Market

• 17.1. Germany Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Foot And Mouth Disease Vaccine Market

• 18.1. France Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Foot And Mouth Disease Vaccine Market

• 19.1. Italy Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Foot And Mouth Disease Vaccine Market

• 20.1. Spain Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Foot And Mouth Disease Vaccine Market

• 21.1. Eastern Europe Foot And Mouth Disease Vaccine Market Overview
• 21.2. Eastern Europe Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Foot And Mouth Disease Vaccine Market

• 22.1. Russia Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Foot And Mouth Disease Vaccine Market

• 23.1. North America Foot And Mouth Disease Vaccine Market Overview
• 23.2. North America Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Foot And Mouth Disease Vaccine Market

• 24.1. USA Foot And Mouth Disease Vaccine Market Overview
• 24.2. USA Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Foot And Mouth Disease Vaccine Market

• 25.1. Canada Foot And Mouth Disease Vaccine Market Overview
• 25.2. Canada Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Foot And Mouth Disease Vaccine Market

• 26.1. South America Foot And Mouth Disease Vaccine Market Overview
• 26.2. South America Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Foot And Mouth Disease Vaccine Market

• 27.1. Brazil Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Foot And Mouth Disease Vaccine Market

• 28.1. Middle East Foot And Mouth Disease Vaccine Market Overview
• 28.2. Middle East Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Foot And Mouth Disease Vaccine Market

• 29.1. Africa Foot And Mouth Disease Vaccine Market Overview
• 29.2. Africa Foot And Mouth Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Foot And Mouth Disease Vaccine Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Foot And Mouth Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Foot And Mouth Disease Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Foot And Mouth Disease Vaccine Market Competitive Landscape
• 30.2. Foot And Mouth Disease Vaccine Market Company Profiles
  • 30.2.1. Godrej Agrovet Limited
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Biogenesis Bago S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Indian Immunologicals Limited
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Limor de Colombia
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Merck & Co. Inc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Foot And Mouth Disease Vaccine Market Competitive Benchmarking

32. Global Foot And Mouth Disease Vaccine Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Foot And Mouth Disease Vaccine Market

34. Foot And Mouth Disease Vaccine Market Future Outlook and Potential Analysis

• 34.1 Foot And Mouth Disease Vaccine Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Foot And Mouth Disease Vaccine Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Foot And Mouth Disease Vaccine Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer